Evidence map›Paper›PMID 28747315›Full record

ArticleJournal of the American Society of Nephrology : JASN2017

Renal Tubular Cell-Derived Extracellular Vesicles Accelerate the Recovery of Established Renal Ischemia Reperfusion Injury.

Jesus H Dominguez, Yunlong Liu, Hongyu Gao, James M Dominguez, Danhui Xie, K J Kelly

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. The role of extracellular vesicles in kidney disease progression.Kidney research and clinical practice · 2026
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jesus H DominguezNephrology Division, Department of Medicine, and.
Yunlong LiuDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana; and.
Hongyu GaoDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana; and.
James M DominguezNephrology Division, Department of Medicine, and.
Danhui XieNephrology Division, Department of Medicine, and.
K J KellyNephrology Division, Department of Medicine, and kajkelly@iu.edu.
Indiana University – Purdue University Indianapolis · USRichard L. Roudebush VA Medical Center · US

Funding

The Postischemia Inflammatory Syndrome in the Aged KidneyR01DK082739 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI KELLY, KATHERINE J · 2010 to 2014
$1.4M
NIDDK NIH HHS R01 DK082739
6 · The paper itself

Abstract

Ischemic renal injury is a complex syndrome; multiple cellular abnormalities cause accelerating cycles of inflammation, cellular damage, and sustained local ischemia. There is no single therapy that effectively resolves the renal damage after ischemia. However, infusions of normal adult rat renal cells have been a successful therapy in several rat renal failure models. The sustained broad renal benefit achieved by relatively few donor cells led to the hypothesis that extracellular vesicles (EV, largely exosomes) derived from these cells are the therapeutic effector

Indexed as

Extracellular VesiclesAcute Kidney InjuryAldehydesAnimalsCell CommunicationDisease Models, AnimalExosomesFemaleGene Expression ProfilingGenotypeHypoxiaKidneyKidney TubulesMicrocirculationNeutrophilsPhenotype4-hydroxy-2-nonenalAldehydesRNA, Messengeracute renal failurecell survivalexosomeshypoxiamRNA

Identifiers

PMID28747315
PMCPMC5698065
OpenAlexW2736459857

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.